L566-0307 Screening compound: N1-(5-chloro-2-methylphenyl)-N3-[(4-fluorophenyl)methyl]-3-methylpiperidine-1,3-dicarboxamide

L566-0307 Screening compound: N1-(5-chloro-2-methylphenyl)-N3-[(4-fluorophenyl)methyl]-3-methylpiperidine-1,3-dicarboxamide
L566-0307 Screening compound: N1-(5-chloro-2-methylphenyl)-N3-[(4-fluorophenyl)methyl]-3-methylpiperidine-1,3-dicarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L566-0307
N1-(5-chloro-2-methylphenyl)-N3-[(4-fluorophenyl)methyl]-3-methylpiperidine-1,3-dicarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L566-0307

Molecular Formula

C22H25ClFN3O2 (C22 H25 ClFN3 O2)

Compound Name

N1-(5-chloro-2-methylphenyl)-N3-[(4-fluorophenyl)methyl]-3-methylpiperidine-1,3-dicarboxamide

IUPAC name

N1-(5-chloro-2-methylphenyl)-N3-[(4-fluorophenyl)methyl]-3-methylpiperidine-13-dicarboxamide

SMILES

CC(CCC1)(CN1C(Nc1c(C)ccc(Cl)c1)=O)C(NCc(cc1)ccc1F)=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

417.91

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

4.065

Distribution Coefficient, logD

4.065

Water Solubility, LogSw

-4.31

Polar Surface Area

49.356

Acid Dissociation Constant (pKa)

11.81

Base Dissociation Constant (pKb)

-3.58

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

36.40

L566-0307 in Drug Discovery

Included in Screening Libraries

CORONAVIRUS Library (20774 compounds)

PLpro Library (6343 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Targeted Diversity Library (40567 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • Others
Mechanism of action:
  • Epigenetic
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with L566-0307 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L566-0307?
Check Price and Availability of L566-0307, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L566-0307 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L566-0307
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L566-0307
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L566-0307 available by request